In the modern world humans have been able to design and create almost anything, especially to help us in our daily lives and improve our standard of living. It is inevitable that humans will eventually use our superior knowledge and abilities to manipulate life itself and change our genome to produce a healthier and even more superior human standard of living. In recent years, the discussion around gene therapy has evolved into a promising possibility for treating many of our most common diseases and disorders. Although gene therapy may be the answer to many problems, it has faced a number of logistical and ethical difficulties. With the prospect of being a treatment for inherited genetic diseases, cancers and viral infections, gene therapy seems like the logical, work-around solution that many people would benefit from. Gene therapy is a relatively new concept, mainly due to our current knowledge. of the human body and the relatively modern understanding of genetic coding and processes. We are now able to better identify and understand the genetic causes of human disorders and are just beginning to understand how to correct, replace or eradicate the chromosomal basis of these problems; this is the concept of gene therapy. However, logistically managing the small structure of genes, chromosomes and DNA is not as easy as repairing a broken wall or a damaged water pipe – we are dealing with complex, microscopic materials that ordinary tools can't handle. Producing such tools to deliver corrective DNA to affected cells within the body is just one of the obstacles facing scientists and researchers. Arthur Bank, a guest reporter for BioJournals, recently explained that virus modification is proving to be an effective method..... .middle of paper......therapy. With further research and development, perhaps it will be possible to take control of the genetic evolution of the human genome. However, it is not surprising that there are some who question the ethical background of such a procedure. Works Cited “An Introduction to Gene Therapy.” Hemophilia 6.(2000): 110-114. Premier of academic research. EBSCO. Network. 16 July 2011. Bank, Arthur. “Human somatic cell gene therapy.” BioEssays 18.12 (1996): 999. Premier Academic Research. EBSCO. Network. July 16, 2011.Southwell, Amber L. and Paul H. Patterson. "Gene therapy in mouse models of Huntington's disease". Neuroscientist 17.2 (2011): 153-162. Premier of academic research. EBSCO. Network. July 16, 2011."Reference for the house of genetics: gene therapy." Genetics Home Reference. US National Library of Medicine, 11 July 2011. Web. 16 July 2011. .